Pol F. Boudes
2023 - Galectin Therapeutics
In 2023, Pol F. Boudes earned a total compensation of $770.3K as M.D., Former Chief Medical Officer at Galectin Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
| Bonus | $160,500 |
|---|---|
| Option Awards | $39,946 |
| Salary | $530,000 |
| Other | $39,834 |
| Total | $770,280 |
Boudes received $530K in salary, accounting for 69% of the total pay in 2023.
Boudes also received $160.5K in bonus, $39.9K in option awards and $39.8K in other compensation.
Rankings
In 2023, Pol F. Boudes' compensation ranked 1,499th out of 3,006 executives tracked by ExecPay. In other words, Boudes earned more than 50.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,499 out of 3,006 | 50th |
Division Manufacturing | 886 out of 1,650 | 46th |
Major group Chemicals And Allied Products | 573 out of 918 | 38th |
Industry group Drugs | 557 out of 881 | 37th |
Industry Pharmaceutical Preparations | 392 out of 637 | 39th |
Source: SEC filing on December 3, 2024.
Boudes' colleagues
We found two more compensation records of executives who worked with Pol F. Boudes at Galectin Therapeutics in 2023.